Geode Capital Management, LLC Rocket Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,752,975 shares of RCKT stock, worth $16.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,752,975

Previous 1,617,866 8.35%

Holding current value

$16.1 Million

Previous $29.9 Million 26.26%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$11.35 - $18.82 $1.53 Million - $2.54 Million	135,109 Added 8.35%	1,752,975 $22 Million
Q3 2024 Nov 12, 2024	BUY	$17.6 - $25.88 $250,905 - $368,945	14,256 Added 0.89%	1,617,866 $29.9 Million
Q2 2024 Aug 09, 2024	BUY	$20.66 - $26.72 $2.09 Million - $2.7 Million	101,023 Added 6.72%	1,603,610 $34.5 Million
Q1 2024 May 13, 2024	BUY	$26.16 - $30.74 $1.19 Million - $1.39 Million	45,337 Added 3.11%	1,502,587 $40.5 Million
Q4 2023 Feb 13, 2024	BUY	$16.78 - $31.94 $3.64 Million - $6.93 Million	217,090 Added 17.5%	1,457,250 $43.7 Million
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $844,778 - $1.35 Million	56,057 Added 4.73%	1,240,160 $25.4 Million
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $470,558 - $669,390	28,364 Added 2.45%	1,184,103 $23.5 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $859,276 - $1.23 Million	54,419 Added 4.94%	1,155,739 $19.8 Million
Q4 2022 Feb 13, 2023	BUY	$15.5 - $22.76 $3.75 Million - $5.51 Million	242,101 Added 28.18%	1,101,320 $21.6 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $627,851 - $934,417	50,756 Added 6.28%	859,219 $13.7 Million
Q2 2022 Aug 12, 2022	BUY	$7.96 - $16.64 $475,418 - $993,840	59,726 Added 7.98%	808,463 $11.1 Million
Q1 2022 May 13, 2022	SELL	$13.16 - $23.68 $77,512 - $139,475	-5,890 Reduced 0.78%	748,737 $11.9 Million
Q4 2021 Feb 11, 2022	BUY	$21.52 - $36.02 $59,524 - $99,631	2,766 Added 0.37%	754,627 $16.5 Million
Q3 2021 Nov 12, 2021	BUY	$27.42 - $48.97 $273,487 - $488,426	9,974 Added 1.34%	751,861 $22.5 Million
Q2 2021 Aug 13, 2021	BUY	$39.41 - $47.25 $2.19 Million - $2.62 Million	55,498 Added 8.09%	741,887 $32.9 Million
Q1 2021 May 12, 2021	BUY	$43.34 - $65.91 $3.72 Million - $5.65 Million	85,749 Added 14.28%	686,389 $30.5 Million
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $1.62 Million - $4.15 Million	69,608 Added 13.11%	600,640 $32.9 Million
Q3 2020 Nov 13, 2020	SELL	$20.5 - $28.59 $369,328 - $515,077	-18,016 Reduced 3.28%	531,032 $12.1 Million
Q2 2020 Aug 13, 2020	BUY	$13.32 - $22.61 $394,165 - $669,075	29,592 Added 5.7%	549,048 $11.5 Million
Q1 2020 May 14, 2020	BUY	$9.71 - $25.11 $496,676 - $1.28 Million	51,151 Added 10.92%	519,456 $7.25 Million
Q4 2019 Feb 13, 2020	BUY	$11.07 - $24.23 $40,449 - $88,536	3,654 Added 0.79%	468,305 $10.7 Million
Q3 2019 Nov 12, 2019	BUY	$10.85 - $14.78 $226,081 - $307,970	20,837 Added 4.69%	464,651 $5.41 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $1.69 Million - $2.23 Million	112,660 Added 34.02%	443,814 $6.66 Million
Q1 2019 May 14, 2019	BUY	$13.45 - $19.01 $458,940 - $648,659	34,122 Added 11.49%	331,154 $5.81 Million
Q4 2018 Feb 13, 2019	BUY	$11.21 - $23.53 $839,886 - $1.76 Million	74,923 Added 33.73%	297,032 $4.4 Million
Q3 2018 Nov 13, 2018	BUY	$18.5 - $25.49 $1.56 Million - $2.14 Million	84,135 Added 60.98%	222,109 $5.47 Million
Q2 2018 Aug 14, 2018	BUY	$14.58 - $23.0 $838,291 - $1.32 Million	57,496 Added 71.44%	137,974 $2.71 Million
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $939,983 - $1.54 Million	80,478 New	80,478 $1.51 Million

Others Institutions Holding RCKT

# of Institutions

244

Shares Held

108M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $697M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Rocket Pharmaceuticals, Inc. Transaction History